Company is bringing its expertise from outside life sciences
Verify Brand (Minneapolis) is no Johnny-come-lately to the serialization/track-and-trace battlefield in life sciences; the company was actually founded (in 2003) in the business, but left it as a matter of survival after the California e-pedigree rules were postponed in 2008. Now, the company is seeing renewed interest among pharma companies, especially those meeting the evolving serialization rules in Turkey, Brazil and elsewhere. This month it took the wraps off VB Enterprise 4.0 for Life Sciences, and coincidentally hired Scott Pugh as director of strategic business development away from Accenture’s life sciences practice.
According Pugh, VB 4.0 is roughly comparable to the enterprise-level data or event-information systems from Axway, IBM or SAP. Verify Brand has rejoined the GS1 organization, and is in the process of getting VB 4.0 certified as EPCIS-compliant. Where Verify hopes to compete against those companies, he says, is in managing the data collection so that the data are tailored to being a “traceability repository” rather than the more conventional “event repository” that is supposed to make track-and-trace data available to trading partners or regulators. “A huge amount of data must be collected and integrated for EPCIS to be effective, and VB 4.0 brings more tools to this problem,” he says.
Verify Brand’s technology has been deployed in global applications outside life sciences; for example, the company’s technology manages the global processes around serializing and authenticating the printer cartridge business of Lexmark (among about 10 other clients). Kevin Erdman, company president, says that the confidence level is rising among pharma prospects that serialization projects will be going forward, regardless of how the push for federal legislation plays out. The company has also partnered with several companies who have substantial operations in life sciences, including marking-equipment vendor Videojet, label converter CCL Label, systems integrator Optel Vision, and the security services unit of 3M.
LogiPharma Unpacked: Highlights, Key Insights, and the Road to 2025
October 16th 2024In this special post-show episode, we sit down with Ryan Portela, Head of Production for LogiPharma, to reflect on the highlights and key takeaways from this year’s event. From attendee feedback to the most impactful sessions, Ryan shares insider insights and discusses how the momentum from 2024 will continue to shape the future of pharma supply chains. Plus, get a sneak peek into the exciting plans for LogiPharma's 20th Anniversary in 2025.
Reimagining Closed-Loop Marketing Strategies for Pharma Companies
November 21st 2024The pharmaceutical industry is evolving, and so are the strategies needed to connect with healthcare professionals. Closed-loop marketing (CLM) has become essential in delivering personalized, data-driven engagement that resonates with physicians and improves key outcomes, such as enhancing patient care, increasing
Maximize Pharma’s Potential with AI-Ready Data for Commercial Excellence
November 21st 2024As the pharmaceutical industry embraces the power of AI, having data that’s large, diverse, and well-structured is critical for driving innovation and improving outcomes. Ensuring your data is AI-ready and can be used with more advanced solutions enables your teams to make informed strategic decisions, predict trends, enhance customer engagements and drive overall strategy.